Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.531.027,59, with a 24-hour trading volume of Rp 36,89T. The asset's market cap is Rp 18,3P, after moving -0.15% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.729.493,36, with a tokenized market cap of Rp 810,81B and a 24-hour trading volume of Rp 34,37B. The tokenized asset has moved -1.82% in the past 24 hours.